Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keitaro Hayashi

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
World Journal of Gastrointestinal Oncology|February 2, 2017
Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatmentKeitaro Hayashi, Naohiko Anzai
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
Filamin A is required for T cell activation mediated by protein kinase C-thetaKeitaro Hayashi, Amnon Altman
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 1, 2022
[Possible therapeutic use of L-type amino acid transporter 1 (LAT1)-specific inhibitor for intractable asthma treatment]Keitaro Hayashi, Osamu Kaminuma
Journal of Pharmacological Sciences|December 20, 2021
L-type amino acid transporter 1 as a target for inflammatory disease and cancer immunotherapyKeitaro Hayashi, Naohiko Anzai
Critical Reviews in Immunology|January 20, 2015
Role of LAT1 in the promotion of amino acid incorporation in activated T cellsKeitaro Hayashi, Naohiko Anzai
Molecular Immunology|January 22, 2011
HSP90 is crucial for regulation of LAT expression in activated T cellsKeitaro Hayashi, Yuichiro Kamikawa
Pharmacological Research|June 5, 2007
Protein kinase C theta (PKCtheta): a key player in T cell life and deathKeitaro Hayashi, Amnon Altman
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 1, 2022
[Preface]Osamu Kaminuma, Keitaro Hayashi
Biomolecules|April 23, 2022
Therapeutic Potential for Intractable Asthma by Targeting L-Type Amino Acid Transporter 1Keitaro Hayashi, Osamu Kaminuma
Theriogenology|August 18, 2020
Na<sup>+</sup>/K<sup>+</sup>-ATPase α4 regulates sperm hyperactivation while Na<sup>+</sup>/K<sup>+</sup>-ATPase α1 regulates basal motility in hamster spermatozoaGen L Takei, Keitaro Hayashi
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
World Journal of Gastrointestinal Oncology|February 2, 2017
Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatmentKeitaro Hayashi, Naohiko Anzai
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
Filamin A is required for T cell activation mediated by protein kinase C-thetaKeitaro Hayashi, Amnon Altman
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 1, 2022
[Possible therapeutic use of L-type amino acid transporter 1 (LAT1)-specific inhibitor for intractable asthma treatment]Keitaro Hayashi, Osamu Kaminuma
Journal of Pharmacological Sciences|December 20, 2021
L-type amino acid transporter 1 as a target for inflammatory disease and cancer immunotherapyKeitaro Hayashi, Naohiko Anzai
Critical Reviews in Immunology|January 20, 2015
Role of LAT1 in the promotion of amino acid incorporation in activated T cellsKeitaro Hayashi, Naohiko Anzai
Molecular Immunology|January 22, 2011
HSP90 is crucial for regulation of LAT expression in activated T cellsKeitaro Hayashi, Yuichiro Kamikawa
Pharmacological Research|June 5, 2007
Protein kinase C theta (PKCtheta): a key player in T cell life and deathKeitaro Hayashi, Amnon Altman
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 1, 2022
[Preface]Osamu Kaminuma, Keitaro Hayashi
Biomolecules|April 23, 2022
Therapeutic Potential for Intractable Asthma by Targeting L-Type Amino Acid Transporter 1Keitaro Hayashi, Osamu Kaminuma
Theriogenology|August 18, 2020
Na<sup>+</sup>/K<sup>+</sup>-ATPase α4 regulates sperm hyperactivation while Na<sup>+</sup>/K<sup>+</sup>-ATPase α1 regulates basal motility in hamster spermatozoaGen L Takei, Keitaro Hayashi
Pageof 5